<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02542592</url>
  </required_header>
  <id_info>
    <org_study_id>HK_VL_08_2015a</org_study_id>
    <secondary_id>2015-000102-19</secondary_id>
    <nct_id>NCT02542592</nct_id>
  </id_info>
  <brief_title>Effect of Methylprednisolone on Immune Signaling in Hip-arthroplasty Patients</brief_title>
  <official_title>Effect of Preoperative Intravenous High Dose Methylprednisolone on Immune Signaling in Patients Scheduled for Total Hip-arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bispebjerg Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study evaluates the pathophysiological effects of a single dose Methylprednisolone
      administered prior to total hip-arthroplasty (THA) surgery. The investigators examine the
      effect on immune signaling and recovery after surgery.

      Half of participants will receive intravenous Solu-Medrol 125 mg, while the other half will
      receive placebo.

      The investigators hypothesize that the group receiving Methylprednisolone will experience a
      positive modulation of the immune response and an enhanced recovery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The anti-inflammatory effects of glucocorticoids are well known. The beneficial effects on
      postoperative pain, postoperative nausea and vomiting are well-documented.

      Hip-arthroplasty surgery and the inflammatory stress response in general affect the potential
      of recovery. The basic physiological mechanisms behind restoration of recovery after surgery
      are still unresolved. The many different immune cells involved in the complex signal response
      enables wound healing and recovery, and the individual immune signal pattern might be able to
      predict recovery. The effects of glucocorticoids on this immune signal pattern is unknown and
      calls for further investigation.

      The study is to be considered as exploratory. This study is embedded in a primary study
      registrated as: NCT02445898

      For further details please view the EudraCT registration:

      EudraCT nr.: 2015-000102-19
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Actual">January 2017</completion_date>
  <primary_completion_date type="Actual">January 2017</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in concentration of plasma-STAT3 (Signal transducer and activator of transcription) from baseline to 48 hours after surgery</measure>
    <time_frame>48 hours after surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in concentration of plasma-STAT3 from baseline to 14 days after surgery</measure>
    <time_frame>14 days after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in concentration of plasma-CREB (Adenosine 3',5'-monophosphate response element-binding protein) from baseline to 14 days after surgery</measure>
    <time_frame>14 days after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in concentration of plasma-NF-kB (Nuclear factor kB) from baseline to 14 days after surgery</measure>
    <time_frame>14 days after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Surgical Recovery Scale score from baseline to 28 days after surgery</measure>
    <time_frame>28 days after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in modified WOMAC (Western Ontario and McMaster Universities Arthritis Index) score from baseline to 28 days after surgery</measure>
    <time_frame>28 days after surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">64</enrollment>
  <condition>Osteoarthrosis</condition>
  <arm_group>
    <arm_group_label>Methylprednisolone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Preoperative single high dose of Solu-Medrol 125 mg iv.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Preoperative single dose of isotonic Sodium Chloride</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Methylprednisolone</intervention_name>
    <description>Comparison of preoperative single high dose of Methylprednisolone 125 mg iv. and isotonic Sodium Chloride (placebo)</description>
    <arm_group_label>Methylprednisolone</arm_group_label>
    <other_name>Solu-Medrol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Isotonic Sodium Chloride</intervention_name>
    <description>Placebo</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Placebo</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Osteoarthrosis

          -  Undergoing total unilateral hip-arthroplasty surgery

          -  Speak and understand Danish

          -  Have given informed content

        Exclusion Criteria:

          -  Revision or bilateral hip-arthroplasty surgery

          -  General anaesthesia

          -  Allergy or intolerance towards Methylprednisolone

          -  Local or systemic infection

          -  Permanent systemic treatment with steroids within 30 days peroperatively

          -  Insulin-dependent diabetes

          -  Atrial fibrillation

          -  Neurological disease incl. Parkinsons

          -  Daily use of hypnotics or sedatives

          -  Alcohol abuse &gt;35 units per week

          -  Active treatment of ulcer within 3 months preoperatively

          -  Cancer disease

          -  Autoimmune disease incl. rheumatoid arthritis

          -  Pregnant or breast feeding women

          -  Menopause &lt;1 year
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Viktoria Lindberg-Larsen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Section for Surgical Pathophysiology, Rigshospitalet</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Copenhagen University Hospital, Bispebjerg</name>
      <address>
        <city>Copenhagen NV</city>
        <zip>2400</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <reference>
    <citation>Stoecklein VM, Osuka A, Lederer JA. Trauma equals danger--damage control by the immune system. J Leukoc Biol. 2012 Sep;92(3):539-51. doi: 10.1189/jlb.0212072. Epub 2012 May 31. Review.</citation>
    <PMID>22654121</PMID>
  </reference>
  <reference>
    <citation>Wilmore DW. From Cuthbertson to fast-track surgery: 70 years of progress in reducing stress in surgical patients. Ann Surg. 2002 Nov;236(5):643-8.</citation>
    <PMID>12409671</PMID>
  </reference>
  <reference>
    <citation>Baigrie RJ, Lamont PM, Kwiatkowski D, Dallman MJ, Morris PJ. Systemic cytokine response after major surgery. Br J Surg. 1992 Aug;79(8):757-60.</citation>
    <PMID>1393463</PMID>
  </reference>
  <reference>
    <citation>Giannoudis PV, Smith RM, Perry SL, Windsor AJ, Dickson RA, Bellamy MC. Immediate IL-10 expression following major orthopaedic trauma: relationship to anti-inflammatory response and subsequent development of sepsis. Intensive Care Med. 2000 Aug;26(8):1076-81.</citation>
    <PMID>11030163</PMID>
  </reference>
  <results_reference>
    <citation>Gaudilli√®re B, Fragiadakis GK, Bruggner RV, Nicolau M, Finck R, Tingle M, Silva J, Ganio EA, Yeh CG, Maloney WJ, Huddleston JI, Goodman SB, Davis MM, Bendall SC, Fantl WJ, Angst MS, Nolan GP. Clinical recovery from surgery correlates with single-cell immune signatures. Sci Transl Med. 2014 Sep 24;6(255):255ra131. doi: 10.1126/scitranslmed.3009701.</citation>
    <PMID>25253674</PMID>
  </results_reference>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 3, 2015</study_first_submitted>
  <study_first_submitted_qc>September 3, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 7, 2015</study_first_posted>
  <last_update_submitted>January 17, 2017</last_update_submitted>
  <last_update_submitted_qc>January 17, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Viktoria Oline Lindberg-Larsen</investigator_full_name>
    <investigator_title>MD, PhD student</investigator_title>
  </responsible_party>
  <keyword>Glucocorticoids</keyword>
  <keyword>Immune Signaling</keyword>
  <keyword>Recovery</keyword>
  <keyword>Hip arthroplasty, total</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prednisolone acetate</mesh_term>
    <mesh_term>Methylprednisolone acetate</mesh_term>
    <mesh_term>Methylprednisolone</mesh_term>
    <mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
    <mesh_term>Prednisolone</mesh_term>
    <mesh_term>Prednisolone hemisuccinate</mesh_term>
    <mesh_term>Prednisolone phosphate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

